Olympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope
Posted:
Olympus Corporation single-use flexible ureteroscopy system, RenaFlex™, has received clearance from the U.S. Food and Drug Administration (FDA) and will soon be available in the United States.
This product assists in the diagnosis and treatment of urological conditions such as #Urolithiasis.
Researchers have begun scanning the first young athletes taking part in a new study using advanced brain imaging to explore the effects of head injuries in 11 to 18-year-olds.
Read more here.
The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us